Class action lawsuit accuses AbbVie of creating ‘patent thicket’ for Humira
AbbVie is once again facing pressure for its alleged attempts to protect its blockbuster medication, Humira, from generics competition.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news